Filter
Investigational Therapies
These compounds and their uses are investigational and have not been approved by the US Food and Drug Administration. Efficacy and safety have not been established. The information presented should not be construed as a recommendation for use. The relevance of findings in preclinical studies to humans is currently being evaluated.
Showing results
Phase III
BREAST
GASTROINTESTINAL
GENITOURINARY
GYNECOLOGIC
HEAD/NECK
HEMATOLOGY
LUNG
MELANOMA
PAN TUMOR
SOLID TUMOR
Phase II
BREAST
GASTROINTESTINAL
GENITOURINARY
GYNECOLOGIC
HEAD/NECK
HEMATOLOGY
LUNG
MELANOMA
Individualized Neoantigen Specific Immunotherapy, iNeST (Personalized Cancer Vaccine, PCV)
(RG6180)f
MELANOMA
SOLID TUMOR
PAN TUMOR
SOLID TUMOR
Individualized Neoantigen Specific Immunotherapy, iNeST (Personalized Cancer Vaccine, PCV)
(RG6180)f
MELANOMA
SOLID TUMOR
Phase I
BREAST
Simlukafusp alfa (FAP x IL2v)
(RG7461)
BREAST
GASTROINTESTINAL
GYNECOLOGIC
HEAD AND NECK
LUNG
MELANOMA
SOLID TUMOR
GASTROINTESTINAL
Atezolizumab
(anti-PD-L1 MAb)
(RG7446)g
GASTROINTESTINAL
GENITOURINARY
HEMATOLOGY
SOLID TUMOR
Simlukafusp alfa (FAP x IL2v)
(RG7461)
BREAST
GASTROINTESTINAL
GYNECOLOGIC
HEAD AND NECK
LUNG
MELANOMA
SOLID TUMOR
GENITOURINARY
Atezolizumab
(anti-PD-L1 MAb)
(RG7446)g
GASTROINTESTINAL
GENITOURINARY
HEMATOLOGY
SOLID TUMOR
GYNECOLOGIC
Simlukafusp alfa (FAP x IL2v)
(RG7461)
BREAST
GASTROINTESTINAL
GYNECOLOGIC
HEAD AND NECK
LUNG
MELANOMA
SOLID TUMOR
HEAD/NECK
Simlukafusp alfa (FAP x IL2v)
(RG7461)
BREAST
GASTROINTESTINAL
GYNECOLOGIC
HEAD AND NECK
LUNG
MELANOMA
SOLID TUMOR
HEMATOLOGY
Atezolizumab
(anti-PD-L1 MAb)
(RG7446)g
GASTROINTESTINAL
GENITOURINARY
HEMATOLOGY
SOLID TUMOR
LUNG
Simlukafusp alfa (FAP x IL2v)
(RG7461)
BREAST
GASTROINTESTINAL
GYNECOLOGIC
HEAD AND NECK
LUNG
MELANOMA
SOLID TUMOR
MELANOMA
Simlukafusp alfa (FAP x IL2v)
(RG7461)
BREAST
GASTROINTESTINAL
GYNECOLOGIC
HEAD AND NECK
LUNG
MELANOMA
SOLID TUMOR
PAN TUMOR
SOLID TUMOR
Atezolizumab
(anti-PD-L1 MAb)
(RG7446)g
GASTROINTESTINAL
GENITOURINARY
HEMATOLOGY
SOLID TUMOR
Simlukafusp alfa (FAP x IL2v)
(RG7461)
BREAST
GASTROINTESTINAL
GYNECOLOGIC
HEAD AND NECK
LUNG
MELANOMA
SOLID TUMOR
Individualized Neoantigen Specific Immunotherapy, iNeST (Personalized Cancer Vaccine, PCV)
(RG6180)f
SOLID TUMOR
aDeveloped in collaboration with Array
BioPharma. bIgnyta, Inc acquisition. cJoint
project with AbbVie. dDeveloped in collaboration with
Exelixis. eDeveloped in collaboration with Chugai.
fDeveloped in collaboration with BioNTech.
gDeveloped in collaboration with Xencor.
hDeveloped in collaboration with Affirmed.
Current
as of October 15, 2020. The trial information is taken from
ClinicalTrials.gov.
Reference
- Roche. YTD September 2020 Sales. https://www.roche.com/dam/jcr:73692497-d80c-4c90-a715-d0d2d9c9520d/en/irp201015.pdf. Accessed October 21, 2020.